HALO logo
halo search icon
CANF
Can-Fite BioPharma Ltd.

CANF · Can-Fite BioPharma Ltd.

3.50

ILS
0.046 (1.33%)
17/09/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

ILS21.21M

PE

1.20

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 17/09/2026 12:00:00 AM

Price Chart

Description

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.

  • All-Companies
  • All-Consensus
  • HALO All
  • HALO Consensus Value
  • HALO Earnings Momentum
  • HALO Growth

Key Fundamentals

EPS 3 yr Growth

-84.00%

EBITDA Margin

NaN%

Operating Cashflow

-$9m

Free Cash Flow Return

-163.00%

ROIC

-179.10%

Interest Coverage

-709.00

Quick Ratio

3.50

Performance

52 weeks range

Low 3.4 - 30

Trade Value (12mth)

US$6,764.00

1 week

-0.23%

1 month

-34.34%

YTD

-88.34%

1 year

-91.03%

All time high

126375.00

Additional Data

Shares Outstanding (Fully Diluted)

4m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Pnina FishmanIndividual
Guy RegevIndividual
Sari FishmanIndividual
Yoseph BornsteinIndividual
Abraham SartaniIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Can-Fite BioPharma Ltd. (CANF:TAE)?
Halo FAQ
The current share price of Can-Fite BioPharma Ltd. (CANF:TAE) is ILS₪3.50.
2
What is the 52-week high share price for Can-Fite BioPharma Ltd. (CANF:TAE)?
Halo FAQ
The 52-week high share price for Can-Fite BioPharma Ltd. (CANF:TAE) is ILS₪30.00.
3
What is the 52-week low share price for Can-Fite BioPharma Ltd. (CANF:TAE)?
Halo FAQ
The 52-week low share price for Can-Fite BioPharma Ltd. (CANF:TAE) is ILS₪3.40.
4
What is the dividend yield for Can-Fite BioPharma Ltd. (CANF:TAE)?
Halo FAQ
Can-Fite BioPharma Ltd. (CANF:TAE) does not pay a dividend.
5
What was Can-Fite BioPharma Ltd. (CANF:TAE) last dividend payment?
Halo FAQ
Can-Fite BioPharma Ltd. (CANF:TAE) does not pay a dividend.
6
What is the franking level for Can-Fite BioPharma Ltd. (CANF:TAE)?
Halo FAQ
Can-Fite BioPharma Ltd. (CANF:TAE) has a franking level of 0.00%.
7
In which sector is Can-Fite BioPharma Ltd. (CANF:TAE) classified?
Halo FAQ
Can-Fite BioPharma Ltd. (CANF:TAE) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Can-Fite BioPharma Ltd. (CANF:TAE)?
Halo FAQ
The current P/E ratio for Can-Fite BioPharma Ltd. (CANF:TAE) is 1.20.